Crypto News1 MIN READ
CRYPTONEUTRAL
Tempus AI (TEM) Stock Soars 11% on Groundbreaking Cancer AI Study and Quarterly Earnings
FG
FOMOGRAM Editorial Desk
Aug 8, 2026
EXECUTIVE SUMMARY
Tempus AI (TEM) stock rallied 11% Friday after Nature Medicine validated its PRISM2 cancer AI model, while reporting its first quarterly profit.
Tempus AI (TEM) stock rallied 11% Friday after Nature Medicine validated its PRISM2 cancer AI model, while reporting its first quarterly profit.
FOMOGRAM SENTINEL GRAVITY TELEMETRY
General news unrelated to monitored cryptocurrencies.
BTC OVERALL MARKET INDEX: 62 / 100 (BULLISH)
Explore all verified news, research, and global sources for CRYPTO.